Feb 21st 2013 - Edison Investment Research today published a report on Global Bioenergies entitled "Proving The Case For Isobutene". In summary, the report says:
Global Bioenergies (GBE) is developing unique biological processes for converting renewable feedstocks into hydrocarbons, which can then be produced on an industrial scale. The next phase of its development will involve building an industrial pilot for isobutene over the next two years, to prove the proprietary process is scalable. If this is successful, the unique patented technology, for a cost-efficient, single-step fermentation process, will be licensed out to industrial partners, producing licence fees and ongoing royalties for GBE. The intention is then to replicate this process for other olefins, where technological progress has already been made.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »